151 related articles for article (PubMed ID: 37770565)
1. Brain-derived neurotrophic factor as a biomarker in cancer-related cognitive impairment among adolescent and young adult cancer patients.
Ng DQ; Cheng I; Wang C; Tan CJ; Toh YL; Koh YQ; Ke Y; Foo KM; Chan RJ; Ho HK; Chew L; Bin Harunal Rashid MF; Chan A
Sci Rep; 2023 Sep; 13(1):16298. PubMed ID: 37770565
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma brain-derived neurotrophic factor levels and self-perceived cognitive impairment post-chemotherapy: a longitudinal study.
Ng T; Lee YY; Chae JW; Yeo AHL; Shwe M; Gan YX; Ng RCH; Chu PPY; Khor CC; Ho HK; Chan A
BMC Cancer; 2017 Dec; 17(1):867. PubMed ID: 29258453
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
4. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment in adolescent and young adult cancer patients: Pre-treatment findings of a longitudinal study.
Chan A; Cheng I; Wang C; Tan CJ; Toh YL; Ng DQ; Koh YQ; Zhou H; Foo KM; Chan RJ; Ho HK; Chew L; Farid M; Tannock I
Cancer Med; 2023 Feb; 12(4):4821-4831. PubMed ID: 36221816
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
[TBL] [Abstract][Full Text] [Related]
8. The effect of smoking on cognition as measured by Cambridge Neuropsychological Test Automated Battery (CATNAB) and brain-derived neurotrophic factor plasma levels.
Al-Mshari AAS; AlSheikh MH; Latif R; Mumtaz S
Saudi Med J; 2020 Dec; 41(12):1308-1314. PubMed ID: 33294889
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
[TBL] [Abstract][Full Text] [Related]
10. Physical exercise improves peripheral BDNF levels and cognitive functions in mild cognitive impairment elderly with different bdnf Val66Met genotypes.
Nascimento CM; Pereira JR; Pires de Andrade L; Garuffi M; Ayan C; Kerr DS; Talib LL; Cominetti MR; Stella F
J Alzheimers Dis; 2015; 43(1):81-91. PubMed ID: 25062900
[TBL] [Abstract][Full Text] [Related]
11. Preliminary Associations Between Brain-Derived Neurotrophic Factor, Memory Impairment, Functional Cognition, and Depressive Symptoms Following Severe TBI.
Failla MD; Juengst SB; Arenth PM; Wagner AK
Neurorehabil Neural Repair; 2016 Jun; 30(5):419-30. PubMed ID: 26276123
[TBL] [Abstract][Full Text] [Related]
12. Effects of smoking on cognition and BDNF levels in a male Chinese population: relationship with BDNF Val66Met polymorphism.
Xia H; Du X; Yin G; Zhang Y; Li X; Cai J; Huang X; Ning Y; Soares JC; Wu F; Zhang XY
Sci Rep; 2019 Jan; 9(1):217. PubMed ID: 30659208
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of BDNF Val66Met polymorphism on neurocognitive functioning in military veterans with and without a history of remote mild traumatic brain injury.
Merritt VC; Clark AL; Evangelista ND; Sorg SF; Schiehser DM; Delano-Wood L
Clin Neuropsychol; 2020 Aug; 34(6):1226-1247. PubMed ID: 32204647
[TBL] [Abstract][Full Text] [Related]
14. Brain-derived neurotrophic factor Val66Met polymorphism and cognitive function in persons with cardiovascular disease.
Szabo AJ; Alosco ML; Miller LA; McGeary JE; Poppas A; Cohen RA; Gunstad J
Psychogeriatrics; 2013 Dec; 13(4):206-12. PubMed ID: 24289461
[TBL] [Abstract][Full Text] [Related]
15. Associations between brain-derived neurotrophic factor and cognitive impairment in panic disorder.
Wang W; Liu Y; Luo S; Guo X; Luo X; Zhang Y
Brain Behav; 2020 Dec; 10(12):e01885. PubMed ID: 33047489
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.
Liu J; Yang W; Luo H; Ma Y; Zhao H; Dan X
Aging Clin Exp Res; 2021 Jun; 33(6):1659-1666. PubMed ID: 32892314
[TBL] [Abstract][Full Text] [Related]
17. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
[TBL] [Abstract][Full Text] [Related]
18. Low plasma BDNF is not a biomarker for cognitive dysfunction in elderly T2DM patients.
Ren QG; Chang JH; Lu WJ; Gong WG; Zhou H
Neurol Sci; 2017 Sep; 38(9):1691-1696. PubMed ID: 28681311
[TBL] [Abstract][Full Text] [Related]
19. Impaired cognitive flexibility during sleep deprivation among carriers of the Brain Derived Neurotrophic Factor (BDNF) Val66Met allele.
Grant LK; Cain SW; Chang AM; Saxena R; Czeisler CA; Anderson C
Behav Brain Res; 2018 Feb; 338():51-55. PubMed ID: 28947280
[TBL] [Abstract][Full Text] [Related]
20. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
Aas M; Haukvik UK; Djurovic S; Bergmann Ø; Athanasiu L; Tesli MS; Hellvin T; Steen NE; Agartz I; Lorentzen S; Sundet K; Andreassen OA; Melle I
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():181-8. PubMed ID: 23876786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
